anmelden
FTSE All-Share
5.735,46
PKT
+15,93
PKT
+0,28
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 06.10.21 | BP Hold | Jefferies & Company Inc. | |
| 06.10.21 | Shell (ex Royal Dutch Shell) Buy | Jefferies & Company Inc. | |
| 06.10.21 | HSBC Buy | UBS AG | |
| 05.10.21 | Rio Tinto Sell | UBS AG | |
| 05.10.21 | Barclays Outperform | Credit Suisse Group | |
| 04.10.21 | GSK Neutral | JP Morgan Chase & Co. | |
| 04.10.21 | Diageo Hold | Kepler Cheuvreux | |
| 04.10.21 | Shell (ex Royal Dutch Shell) Overweight | Barclays Capital | |
| 04.10.21 | Shell (ex Royal Dutch Shell) Overweight | Barclays Capital | |
| 04.10.21 | BP Overweight | Barclays Capital | |
| 01.10.21 | Diageo Outperform | Credit Suisse Group | |
| 01.10.21 | Unilever Sell | UBS AG | |
| 01.10.21 | Diageo Sector Perform | RBC Capital Markets | |
| 01.10.21 | Diageo Buy | UBS AG | |
| 01.10.21 | Diageo Buy | Goldman Sachs Group Inc. | |
| 01.10.21 | Diageo Neutral | JP Morgan Chase & Co. | |
| 30.09.21 | Vodafone Group Buy | UBS AG | |
| 30.09.21 | Diageo Sector Perform | RBC Capital Markets | |
| 30.09.21 | Diageo Neutral | JP Morgan Chase & Co. | |
| 30.09.21 | Vodafone Group Buy | Deutsche Bank AG | |
| 30.09.21 | Barclays Buy | Jefferies & Company Inc. | |
| 29.09.21 | Unilever Underweight | JP Morgan Chase & Co. | |
| 29.09.21 | AstraZeneca Buy | Deutsche Bank AG | |
| 29.09.21 | Rio Tinto Equal-weight | Morgan Stanley | |
| 29.09.21 | Lloyds Banking Group Neutral | Goldman Sachs Group Inc. | |
| 28.09.21 | AstraZeneca Outperform | Credit Suisse Group | |
| 28.09.21 | AstraZeneca Buy | Jefferies & Company Inc. | |
| 28.09.21 | Prudential Buy | Deutsche Bank AG | |
| 28.09.21 | Unilever Buy | Goldman Sachs Group Inc. | |
| 27.09.21 | Prudential Outperform | RBC Capital Markets | |
| 27.09.21 | Vodafone Group Outperform | Credit Suisse Group | |
| 24.09.21 | AstraZeneca Overweight | Barclays Capital | |
| 24.09.21 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 24.09.21 | AstraZeneca Buy | UBS AG | |
| 24.09.21 | GSK Neutral | UBS AG | |
| 24.09.21 | Shell (ex Royal Dutch Shell) Buy | UBS AG | |
| 24.09.21 | AstraZeneca Buy | Jefferies & Company Inc. | |
| 23.09.21 | Vodafone Group Buy | UBS AG | |
| 23.09.21 | Vodafone Group Conviction Buy List | Goldman Sachs Group Inc. | |
| 23.09.21 | AstraZeneca Outperform | Credit Suisse Group |